uBriGene is pleased to announce our participation in the 9th CAR-TCR Summit, an esteemed event dedicated to advancing cell therapy for oncology and autoimmune diseases. The summit will be held on September 18-19, 2024, at the Hynes Convention Center in Boston, US.
We cordially invite you to visit our booth #13 to explore our innovative cell and gene therapy platforms and products. Our team of experts will be available to discuss the latest industry trends, engage in meaningful conversations, and explore potential collaborations. We look forward to connecting with you and discussing how our technologies can support your goals.
Event Details:
Date: Sep 18 – 19
Location: Hynes Convention Center, Boston, US
Booth: 13
Exclusive Lunch Session
On Thursday, September 19, uBriGene will host an exclusive Lunch and Learn session from 1:00 pm to 2:00 pm, room #204. This event will coincide with the regular conference lunch, providing an opportunity to enjoy a gourmet buffet in a more serene setting, away from the typical lunchtime crowds.
Dr. Xiulian Sun, Founder and Chief Technical Officer of uBriGene, will present "How Technology Innovations Can Make CGT More Affordable." Key topics will include:
LVV Suspension Cells: Demonstrating 5-10 fold higher productivity.
CircRNA Purity: Achieving 94% purity and 80% integrity for saRNA.
sgRNA IVT: Offering a more cost-effective and efficient alternative to chemical synthesis for gene editing.
This Lunch session provides a valuable opportunity to network with industry leaders and gain insights into the latest advancements in cell and gene therapy. Given the limited availability of spaces, we encourage you to RSVP by Friday, August 16, to secure your attendance.
We look forward to welcoming you to the 9th CAR-TCR Summit and sharing how uBriGene is contributing to the future of cell therapy.
For conference registration and further details about the CAR-TCR Summit, please contact the event organizer directly.
Contact Us | uBriGene right now to speak with our Cell and Gene Therapy professionals to learn how uBriGene's extensive service portfolio can help to accelerate your project.
Join us and be part of the future of ATMPs with uBriGene via our website Your bridge from ATMPs concept to commercialization | uBriGene!
Follow us on LinkedIn and subscribe to our newsletter to stay informed about our latest developments and announcements.
Comments